Reckitt Benckiser is the seventh largest consumer health company, with sales mainly in the US and the UK. Over 2018-2021, its OTC sales grew 4% tied to the acquisition of Biofreeze in 2021 and from strong growth in vitamins and dietary supplements during COVID-19. RB’s portfolio is weighted towards a few categories, making brand diversification, customer expansion and sustainability goals critical. The US, the UK and China will drive future growth, particularly in cough/cold and dietary suppleme
Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).
This report comes in PPT.
Euromonitor International's report on Reckitt Benckiser Group Plc (RB) delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Reckitt Benckiser Group Plc (RB), while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Reckitt Benckiser Group Plc (RB).
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and WellbeingSee All of Our Definitions
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!